MIST Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 19.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $97,875.00

Milestone Pharmaceuticals Insider Trading History Chart

Milestone Pharmaceuticals Share Price & Price History

^$2.04

▼ -0.15 (-6.85%)

As of 01/9/2026 05:00 PM ET

Days: 30 | 90 | 365

Milestone Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/8/2026	Joseph Oliveto	CEO	Sell	43,000	$2.25	$96,750.00	303,721
1/7/2026	Joseph Oliveto	CEO	Sell	500	$2.25	$1,125.00	346,721

SEC Filings (Institutional Ownership Changes) for Milestone Pharmaceuticals (NASDAQ:MIST)

86.18% of Milestone Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Milestone Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
1/9/2026	SG Americas Securities LLC	97,375	$0.20M	0.0%	N/A	0.114%
1/7/2026	Bay Rivers Group	28,861	$58K	0.0%	+72.9%	0.034%
11/17/2025	Millennium Management LLC	401,559	$0.80M	0.0%	N/A	0.471%
11/17/2025	Boxer Capital Management LLC	666,666	$1.33M	0.4%	N/A	0.783%
11/17/2025	Bank of America Corp DE	16,052	$32K	0.0%	+200,550.0%	0.019%
11/14/2025	Raymond James Financial Inc.	26,600	$53K	0.0%	-38.5%	0.031%
11/14/2025	Orbimed Advisors LLC	3,221,828	$6.44M	0.2%	N/A	3.791%
11/14/2025	Two Sigma Investments LP	666,551	$1.33M	0.0%	N/A	0.784%
11/13/2025	Pathstone Holdings LLC	1,000,000	$2M	0.0%	N/A	1.177%
11/13/2025	UBS Group AG	397,534	$0.80M	0.0%	+23.2%	0.468%
11/12/2025	Aptus Capital Advisors LLC	210,200	$0.42M	0.0%	N/A	0.247%
11/12/2025	Propel Bio Management LLC	5,124,890	$10.25M	10.3%	+186.1%	6.030%
11/7/2025	GSA Capital Partners LLP	78,747	$0.16M	0.0%	N/A	0.093%
10/29/2025	AMH Equity Ltd	231,671	$0.46M	0.6%	N/A	0.273%
10/21/2025	Stephenson & Company Inc.	20,000	$40K	0.0%	N/A	0.024%
10/20/2025	Simplify Asset Management Inc.	2,832,974	$5.67M	0.1%	+186.2%	3.333%
10/17/2025	Sapient Capital LLC	12,200	$25K	0.0%	N/A	0.014%
9/12/2025	Valeo Financial Advisors LLC	130,699	$0.25M	0.0%	+553.5%	0.154%
8/14/2025	Raymond James Financial Inc.	43,235	$84K	0.0%	+30.1%	0.081%
8/13/2025	Walleye Capital LLC	15,109	$29K	0.0%	-83.6%	0.028%
8/12/2025	XTX Topco Ltd	160,963	$0.31M	0.0%	+209.5%	0.301%
8/8/2025	Creative Planning	23,410	$45K	0.0%	+74.6%	0.044%
8/7/2025	Simplify Asset Management Inc.	990,000	$1.92M	0.1%	+16.5%	1.852%
7/22/2025	Valeo Financial Advisors LLC	130,699	$0.25M	0.0%	+553.5%	0.244%
7/9/2025	Bay Rivers Group	14,321	$28K	0.0%	N/A	0.027%
5/15/2025	Propel Bio Management LLC	1,451,557	$1.16M	1.3%	N/A	2.715%
5/14/2025	Stonepine Capital Management LLC	250,000	$0.20M	0.2%	-50.0%	0.468%
5/14/2025	Walleye Capital LLC	91,920	$74K	0.0%	N/A	0.172%
5/12/2025	Alta Fundamental Advisers LLC	1,427,479	$1.14M	0.7%	-46.3%	2.670%
5/8/2025	XTX Topco Ltd	52,004	$42K	0.0%	+52.7%	0.097%
2/19/2025	Toronto Dominion Bank	750,000	$1.77M	0.0%	N/A	1.406%
2/17/2025	Stonepine Capital Management LLC	500,000	$1.18M	1.0%	-50.0%	0.938%
2/17/2025	Toronto Dominion Bank	750,000	$1.77M	0.0%	N/A	1.406%
2/17/2025	RTW Investments LP	2,506,102	$5.91M	0.1%	-23.0%	4.699%
2/17/2025	Millennium Management LLC	2,703,259	$6.38M	0.0%	-2.7%	5.069%
2/17/2025	Lion Point Capital LP	1,025,806	$2.42M	12.7%	-38.0%	1.924%
2/17/2025	Cubist Systematic Strategies LLC	30,938	$73K	0.0%	N/A	0.058%
2/14/2025	Boxer Capital Management LLC	309,007	$0.73M	0.1%	N/A	0.579%
2/14/2025	Nantahala Capital Management LLC	1,445,264	$3.41M	0.1%	-17.4%	2.710%
2/14/2025	Northern Trust Corp	58,108	$0.14M	0.0%	+112.6%	0.109%
2/14/2025	Two Sigma Securities LLC	16,957	$40K	0.0%	-26.7%	0.032%
2/13/2025	XTX Topco Ltd	34,054	$80K	0.0%	N/A	0.064%
2/13/2025	Envestnet Asset Management Inc.	63,742	$0.15M	0.0%	-9.7%	0.120%
2/12/2025	National Bank of Canada FI	18,700	$44K	0.0%	+163.4%	0.035%
2/11/2025	Virtu Financial LLC	71,955	$0.17M	0.0%	N/A	0.135%
2/6/2025	Jones Financial Companies Lllp	11,000	$26K	0.0%	+1,000.0%	0.021%
1/24/2025	Clear Creek Financial Management LLC	10,500	$25K	0.0%	-46.2%	0.020%
11/25/2024	PVG Asset Management Corp	30,345	$46K	0.2%	N/A	0.057%
11/14/2024	Stonepine Capital Management LLC	999,790	$1.52M	1.0%	-19.3%	1.877%
11/5/2024	BML Capital Management LLC	1,136,091	$1.73M	1.0%	+3.0%	2.133%
11/1/2024	Atria Investments Inc	40,421	$61K	0.0%	+44.4%	0.076%
10/10/2024	Valeo Financial Advisors LLC	20,000	$30K	0.0%	+100.0%	0.038%
8/21/2024	Stonepine Capital Management LLC	1,239,199	$1.64M	1.5%	-15.3%	2.327%
8/15/2024	Lion Point Capital LP	2,340,207	$3.09M	5.6%	+1.7%	4.394%
8/15/2024	Millennium Management LLC	2,749,930	$3.66M	0.0%	-3.7%	5.163%
5/1/2024	BNP Paribas Financial Markets	16,900	$30K	0.0%	+177.0%	0.032%
4/26/2024	Clear Creek Financial Management LLC	25,000	$45K	0.0%	-21.3%	0.047%
4/23/2024	BML Capital Management LLC	606,145	$1.09M	0.7%	+37.0%	1.140%
1/30/2024	BML Capital Management LLC	442,352	$0.74M	0.6%	+62.3%	1.321%
9/21/2023	Barclays PLC	800,776	$2.28M	0.0%	-5.4%	2.399%
8/21/2023	Affinity Asset Advisors LLC	300,068	$0.86M	0.3%	+50.5%	0.899%
8/11/2023	Beta Wealth Group Inc.	14,127	$40K	0.0%	N/A	0.042%
8/3/2023	Barclays PLC	800,776	$2.28M	0.0%	-5.4%	2.400%
7/27/2023	Virtu Financial LLC	11,743	$33K	0.0%	N/A	0.035%
7/24/2023	BML Capital Management LLC	272,500	$0.78M	0.7%	+23.9%	0.817%
7/17/2023	Clear Creek Financial Management LLC	31,929	$91K	0.0%	-11.1%	0.096%
7/14/2023	Valeo Financial Advisors LLC	118,699	$0.34M	0.0%	+4.4%	0.356%
5/16/2023	Alta Fundamental Advisers LLC	897,961	$3.54M	1.5%	+58.8%	2.698%
5/15/2023	Affinity Asset Advisors LLC	199,382	$0.79M	0.3%	+99.4%	0.599%
5/15/2023	RTW Investments LP	3,256,102	$12.83M	0.3%	-24.5%	9.782%
5/4/2023	Barclays PLC	846,828	$3.34M	0.0%	+32.0%	2.544%
4/20/2023	Clear Creek Financial Management LLC	35,929	$0.14M	0.0%	N/A	0.108%
4/14/2023	BML Capital Management LLC	220,000	$0.87M	0.7%	+22.2%	0.661%
2/15/2023	Braidwell LP	1,164,849	$4.61M	0.2%	N/A	3.397%
2/14/2023	VR Adviser LLC	2,208,812	$8.75M	1.4%	-8.9%	6.442%
2/14/2023	Pura Vida Investments LLC	371,788	$1.47M	0.1%	-37.7%	1.084%
2/13/2023	BML Capital Management LLC	180,000	$0.71M	0.7%	N/A	0.525%
2/13/2023	Beta Wealth Group Inc.	14,127	$56K	0.0%	N/A	0.041%
2/9/2023	Valeo Financial Advisors LLC	113,699	$0.45M	0.0%	+50.6%	0.332%
2/1/2023	Bank of Montreal Can	152,636	$0.61M	0.0%	+217.3%	0.445%
11/15/2022	Pura Vida Investments LLC	596,531	$5.48M	0.3%	-39.6%	1.740%
11/15/2022	Boxer Capital LLC	698,861	$6.42M	0.4%	-68.8%	2.038%
11/14/2022	LMR Partners LLP	38,495	$0.35M	0.0%	+228.1%	0.128%
11/14/2022	VR Adviser LLC	2,425,737	$22.29M	3.3%	N/A	8.083%
11/3/2022	Barclays PLC	540,582	$4.97M	0.0%	+155.3%	1.801%
10/31/2022	Valeo Financial Advisors LLC	75,500	$0.69M	0.0%	N/A	0.252%
10/13/2022	National Bank of Canada FI	2,880	$26K	0.0%	-80.6%	0.010%
8/15/2022	Acuta Capital Partners LLC	457,200	$2.81M	1.6%	+20.3%	1.528%
2/14/2022	Boxer Capital LLC	2,238,861	$14.67M	0.6%	-13.0%	7.501%
2/14/2022	Eversept Partners LP	147,165	$0.96M	0.1%	+29.6%	0.493%
2/10/2022	Bleichroeder LP	250,000	$1.64M	0.3%	N/A	0.838%
2/10/2022	Acadian Asset Management LLC	12,381	$79K	0.0%	+63.0%	0.041%
1/24/2022	National Bank of Canada FI	14,742	$96K	0.0%	N/A	0.049%
11/16/2021	Millennium Management LLC	695,241	$3.97M	0.0%	-3.3%	2.329%
11/15/2021	Pura Vida Investments LLC	850,312	$4.86M	0.1%	+21.0%	2.849%
11/15/2021	Eversept Partners LP	113,597	$0.65M	0.0%	N/A	0.381%
11/9/2021	Barclays PLC	200,688	$1.15M	0.0%	-1.6%	0.672%

Data available starting January 2016

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans, as well as with the Montreal Heart Institute, the WCN network, and other research centers. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

Today's Range

Now: $2.04

$1.98

$2.19

50 Day Range

MA: $2.23

$1.71

$2.95

52 Week Range

Now: $2.04

$0.63

$3.06

Volume

6,348,983 shs

Average Volume

9,389,983 shs

Market Capitalization

$173.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.44

Who are the company insiders with the largest holdings of Milestone Pharmaceuticals?: Milestone Pharmaceuticals' top insider shareholders include:
Joseph Oliveto (CEO)
Learn More about top insider investors at Milestone Pharmaceuticals.
Who are the major institutional investors of Milestone Pharmaceuticals?: Milestone Pharmaceuticals' top institutional investors include:
SG Americas Securities LLC — 0.11%
Bay Rivers Group — 0.03%
Learn More about top institutional investors of Milestone Pharmaceuticals stock.
Which major investors are buying Milestone Pharmaceuticals stock?: During the previous quarter, MIST stock was bought by institutional investors including:
SG Americas Securities LLC
Bay Rivers Group